search
Back to results

Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)

Primary Purpose

Obstructive Defecation Syndrome, Chronic Constipation, Rectocele

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Stapled Transanal Resection (STARR) with Transtar (PROXIMATE®) 33 mm Circular Stapler
Sponsored by
Ethicon Endo-Surgery
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obstructive Defecation Syndrome focused on measuring Obstructive Defecation Syndrome, Colorectal Surgery, Defecography, Constipation, Rectocele, Intussusception, Quality of Life

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Able to comprehend, understand, and speak the English language Able to comprehend, follow, and sign an informed consent document (ICD) Able to tolerate general or spinal anesthetic Often experience excessive straining, sense of incomplete evacuation, and/or prolonged time for complete evacuation when attempting a bowel movement Have experienced ODS symptoms for at least 12 months prior to enrollment Have a minimum ODS score of 10 Have rectocele and/or rectal intussusception confirmed by defecography Screened for colorectal neoplasia within 7 years of the screening visit (e.g., colonoscopy or barium enema) Have an American Society of Anesthesiologists (ASA) score of no more than 3 Willing to comply with evaluation and management schedule through 5-year follow-up Exclusion Criteria: Fecal incontinence to solid stool Full-thickness prolapse Perineal infection Recto-vaginal fistula Enterocele (at rest) Any complex pelvic floor prolapse requiring a combined surgical approach Prior sigmoid or anterior resection or prior rectal anastomosis Presence of foreign material adjacent to the rectum (e.g., vaginal mesh) Grade IV hemorrhoids Pregnancy Chronic narcotic use Evidence of colorectal neoplasia, carcinoma, or inflammatory bowel disease Physical or psychological condition which would impair study participation Unable or unwilling to attend follow-up visits and examinations Surgical procedure required concurrently with STARR Prior pelvic radiotherapy Failure to identify any anatomical or physiological abnormality in the evaluation Significant rectal fibrosis Anal stenosis precluding insertion of the stapling device Participation in any other investigational device or drug study 30 days prior to enrollment Presence or history of hepatitis B, hepatitis C, and/or HIV positive test

Sites / Locations

  • Colon and Rectal Clinic of Orlando
  • Lahey Clinic
  • Colon & Rectal Surgery Associates Ltd.
  • University Hospitals of Cleveland
  • The Cleveland Clinic Foundation
  • Medical University of Ohio, Department of Surgery
  • Portland Medical Center

Outcomes

Primary Outcome Measures

Percentage of Change (Reduction) in Total ODS Symptom Composite Score From Baseline to One Year Post Procedure
The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.

Secondary Outcome Measures

Percentage of Change in ODS Symptom Composite Score From Baseline at 1 Month Post Procedure
Percentage of change in Obstructive Defecation Syndrome (ODS) symptom composite score from baseline at 1 month post procedure. This score is based on a series of questions designed to understand the extent ODS effects an individual's daily lifestyle (0 is worst score, 24 is best score). Sizing consistent with primary outcome; analysis was per-protocol.
Maximum Change in Subject-reported Assessment of Symptom Severity and Frequency (PAC SYM).
Assessed as patient-reported assessment of symptom severity and frequency (PAC-SYM)associated with constipation. Patient response options are absent, mild, moderate, severe, and very severe.12 questions relate to severity, 8 questions relate to frequency of symptoms. The lower the score, the less severe the symptoms. Sizing consistent with primary outcome; analysis was per-protocol.
Percentage of Change in ODS Symptom Composite Score From Baseline at 6 Months (0 is Worst Score, 24 is Best Score)
The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.
PAC QOL Patient Assessment of Constipation (Overall)
PAC-QOL is Patient Assessment of Constipation, Quality of Life. The instrument consists of 28 questions on a 0-4 scale. A lower score indicates better quality of life. The score is a number without units.Change from baseline in patient assessment of constipation in quality of life as measured by the PAC QOL instrument score. The questions are designed to measure the impact constipation has had on daily life during the week prior to the subject visit. Sizing was consistent with the primary outcome; analysis was per-protocol
SF-12 QOL Change From Baseline (Physical Component)at 12 Months
The SF-12 is a validated 12 question quality-of-life questionnaire. The SF-12 extracts 12 items from the SF-36 questionnaire in two six-item subscales, PCS (physical functioning) and MCS (emotional functioning). The SF-12 scores can range from 10 (maximum impairment) to 70 (no impairment). For this study, the endpoint is the percentage of change from baseline over 12 months post procedure.
SF-12 QOL Change (Mental Component) at 12 Months From Baseline
SF 12 change from baseline, mental component. The SF-12 is a validated 12 question quality-of-life questionnaire. The SF-12 extracts 12 items from the SF-36 questionnaire in two six-item subscales, PCS (physical functioning) and MCS (emotional functioning). The SF-36 scores range from 0 (maximum impairment) to 100 (no impairment), the SF-12 scores range from 10 (maximum impairment) to 70 (no impairment). For this study, the endpoint is the percentage of change from baseline over 12 months post procedure.

Full Information

First Posted
November 18, 2005
Last Updated
October 9, 2017
Sponsor
Ethicon Endo-Surgery
search

1. Study Identification

Unique Protocol Identification Number
NCT00256984
Brief Title
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
Official Title
A Multi-center Study to Assess the Outcomes of Stapled Trans-Anal Rectal Resection (STARR) in the Treatment of Obstructed Defecation Syndrome (ODS)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
October 1, 2005 (Actual)
Primary Completion Date
March 1, 2008 (Actual)
Study Completion Date
June 1, 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ethicon Endo-Surgery

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary purpose of this study is to determine how effective and how durable STARR (stapled transanal rectal resection) surgery is in relieving symptoms of intractable constipation associated with obstructive defecation syndrome (ODS).
Detailed Description
Rectocele and rectal intussusception are frequent findings in women but are often asymptomatic apart from anatomical defects, which can be seen on vaginal examination. They can be associated, however, with refractory constipation that may be best described by the terms "Outlet Obstruction" or "Obstructive Defecation Syndrome (ODS)". ODS is characterized by a symptom complex, including the feeling of incomplete evacuation associated with the need to strain excessively and for external assistance (digital, mechanical or positional maneuvers, enemas or suppositories) to aid defecation. Abdominal or rectal pain is also a common complaint. Obstetric trauma is also recognized as a contributing factor. However, none of these symptoms/factors can be singled out to be pathognomonic for this problem. ODS has a prevalence of approximately 12% in the general population. For individuals with ODS and related intussusception/rectocele, a variety of surgical techniques including abdominal, vaginal, transanal and perineal approaches have been devised. The impact of clinical studies to evaluate these techniques has been limited by variability of results and lack of comparators. Recently, a new surgical approach was developed by an Italian surgeon, A. Longo, and has been evaluated in several European centers. These early studies and observations indicate that this new procedure may in fact provide significantly better symptom resolution in ODS patients than other available treatments, and warrants further study. The procedure is referred to as "Stapled Transanal Rectal Resection (STARR)" and this study will assess its effectiveness in a United States population.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Defecation Syndrome, Chronic Constipation, Rectocele, Intussusception
Keywords
Obstructive Defecation Syndrome, Colorectal Surgery, Defecography, Constipation, Rectocele, Intussusception, Quality of Life

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Stapled Transanal Resection (STARR) with Transtar (PROXIMATE®) 33 mm Circular Stapler
Primary Outcome Measure Information:
Title
Percentage of Change (Reduction) in Total ODS Symptom Composite Score From Baseline to One Year Post Procedure
Description
The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.
Time Frame
one year from Baseline
Secondary Outcome Measure Information:
Title
Percentage of Change in ODS Symptom Composite Score From Baseline at 1 Month Post Procedure
Description
Percentage of change in Obstructive Defecation Syndrome (ODS) symptom composite score from baseline at 1 month post procedure. This score is based on a series of questions designed to understand the extent ODS effects an individual's daily lifestyle (0 is worst score, 24 is best score). Sizing consistent with primary outcome; analysis was per-protocol.
Time Frame
Baseline, 1 month post procedure
Title
Maximum Change in Subject-reported Assessment of Symptom Severity and Frequency (PAC SYM).
Description
Assessed as patient-reported assessment of symptom severity and frequency (PAC-SYM)associated with constipation. Patient response options are absent, mild, moderate, severe, and very severe.12 questions relate to severity, 8 questions relate to frequency of symptoms. The lower the score, the less severe the symptoms. Sizing consistent with primary outcome; analysis was per-protocol.
Time Frame
Baseline, 6 months
Title
Percentage of Change in ODS Symptom Composite Score From Baseline at 6 Months (0 is Worst Score, 24 is Best Score)
Description
The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.
Time Frame
Baseline, 6 months post procedure
Title
PAC QOL Patient Assessment of Constipation (Overall)
Description
PAC-QOL is Patient Assessment of Constipation, Quality of Life. The instrument consists of 28 questions on a 0-4 scale. A lower score indicates better quality of life. The score is a number without units.Change from baseline in patient assessment of constipation in quality of life as measured by the PAC QOL instrument score. The questions are designed to measure the impact constipation has had on daily life during the week prior to the subject visit. Sizing was consistent with the primary outcome; analysis was per-protocol
Time Frame
Baseline, 12 months
Title
SF-12 QOL Change From Baseline (Physical Component)at 12 Months
Description
The SF-12 is a validated 12 question quality-of-life questionnaire. The SF-12 extracts 12 items from the SF-36 questionnaire in two six-item subscales, PCS (physical functioning) and MCS (emotional functioning). The SF-12 scores can range from 10 (maximum impairment) to 70 (no impairment). For this study, the endpoint is the percentage of change from baseline over 12 months post procedure.
Time Frame
Baseline, 12 Months
Title
SF-12 QOL Change (Mental Component) at 12 Months From Baseline
Description
SF 12 change from baseline, mental component. The SF-12 is a validated 12 question quality-of-life questionnaire. The SF-12 extracts 12 items from the SF-36 questionnaire in two six-item subscales, PCS (physical functioning) and MCS (emotional functioning). The SF-36 scores range from 0 (maximum impairment) to 100 (no impairment), the SF-12 scores range from 10 (maximum impairment) to 70 (no impairment). For this study, the endpoint is the percentage of change from baseline over 12 months post procedure.
Time Frame
Baseline, 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Able to comprehend, understand, and speak the English language Able to comprehend, follow, and sign an informed consent document (ICD) Able to tolerate general or spinal anesthetic Often experience excessive straining, sense of incomplete evacuation, and/or prolonged time for complete evacuation when attempting a bowel movement Have experienced ODS symptoms for at least 12 months prior to enrollment Have a minimum ODS score of 10 Have rectocele and/or rectal intussusception confirmed by defecography Screened for colorectal neoplasia within 7 years of the screening visit (e.g., colonoscopy or barium enema) Have an American Society of Anesthesiologists (ASA) score of no more than 3 Willing to comply with evaluation and management schedule through 5-year follow-up Exclusion Criteria: Fecal incontinence to solid stool Full-thickness prolapse Perineal infection Recto-vaginal fistula Enterocele (at rest) Any complex pelvic floor prolapse requiring a combined surgical approach Prior sigmoid or anterior resection or prior rectal anastomosis Presence of foreign material adjacent to the rectum (e.g., vaginal mesh) Grade IV hemorrhoids Pregnancy Chronic narcotic use Evidence of colorectal neoplasia, carcinoma, or inflammatory bowel disease Physical or psychological condition which would impair study participation Unable or unwilling to attend follow-up visits and examinations Surgical procedure required concurrently with STARR Prior pelvic radiotherapy Failure to identify any anatomical or physiological abnormality in the evaluation Significant rectal fibrosis Anal stenosis precluding insertion of the stapling device Participation in any other investigational device or drug study 30 days prior to enrollment Presence or history of hepatitis B, hepatitis C, and/or HIV positive test
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robin F Scamuffa, MS
Organizational Affiliation
Ethicon Endo-Surgery
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
William Bernie, MD
Organizational Affiliation
Ethicon Endo-Surgery
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Anthony J Senagore, MD
Organizational Affiliation
Medical University of Ohio
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Anders F Mellgren, MD, PhD
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
Colon and Rectal Clinic of Orlando
City
Orlando
State/Province
Florida
ZIP/Postal Code
32806
Country
United States
Facility Name
Lahey Clinic
City
Burlington
State/Province
Massachusetts
ZIP/Postal Code
01805
Country
United States
Facility Name
Colon & Rectal Surgery Associates Ltd.
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55454
Country
United States
Facility Name
University Hospitals of Cleveland
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Facility Name
The Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Medical University of Ohio, Department of Surgery
City
Toledo
State/Province
Ohio
ZIP/Postal Code
43614
Country
United States
Facility Name
Portland Medical Center
City
Portland
State/Province
Oregon
ZIP/Postal Code
97205
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
2612988
Citation
Shorvon PJ, McHugh S, Diamant NE, Somers S, Stevenson GW. Defecography in normal volunteers: results and implications. Gut. 1989 Dec;30(12):1737-49. doi: 10.1136/gut.30.12.1737.
Results Reference
background
PubMed Identifier
10384970
Citation
Kenton K, Shott S, Brubaker L. The anatomic and functional variability of rectoceles in women. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(2):96-9. doi: 10.1007/pl00004019.
Results Reference
background
PubMed Identifier
8359649
Citation
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep;105(3):781-90. doi: 10.1016/0016-5085(93)90896-k.
Results Reference
background
PubMed Identifier
7552638
Citation
Siproudhis L, Dautreme S, Ropert A, Briand H, Renet C, Beusnel C, Juguet F, Rabot AF, Bretagne JF, Gosselin M. Anismus and biofeedback: who benefits? Eur J Gastroenterol Hepatol. 1995 Jun;7(6):547-52.
Results Reference
background
PubMed Identifier
11089592
Citation
van Dam JH, Hop WC, Schouten WR. Analysis of patients with poor outcome of rectocele repair. Dis Colon Rectum. 2000 Nov;43(11):1556-60. doi: 10.1007/BF02236738.
Results Reference
background
PubMed Identifier
1586766
Citation
Fleshman JW, Fry RD, Kodner IJ. The surgical management of constipation. Baillieres Clin Gastroenterol. 1992 Mar;6(1):145-62. doi: 10.1016/0950-3528(92)90024-9.
Results Reference
background
PubMed Identifier
12432306
Citation
Altomare DF, Rinaldi M, Veglia A, Petrolino M, De Fazio M, Sallustio P. Combined perineal and endorectal repair of rectocele by circular stapler: a novel surgical technique. Dis Colon Rectum. 2002 Nov;45(11):1549-52. doi: 10.1007/s10350-004-6465-9.
Results Reference
background
PubMed Identifier
14628157
Citation
Dodi G, Pietroletti R, Milito G, Binda G, Pescatori M. Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation. Tech Coloproctol. 2003 Oct;7(3):148-53. doi: 10.1007/s10151-003-0026-4.
Results Reference
background
PubMed Identifier
15484341
Citation
Boccasanta P, Venturi M, Stuto A, Bottini C, Caviglia A, Carriero A, Mascagni D, Mauri R, Sofo L, Landolfi V. Stapled transanal rectal resection for outlet obstruction: a prospective, multicenter trial. Dis Colon Rectum. 2004 Aug;47(8):1285-96; discussion 1296-7. doi: 10.1007/s10350-004-0582-3.
Results Reference
background
PubMed Identifier
15024596
Citation
Boccasanta P, Venturi M, Salamina G, Cesana BM, Bernasconi F, Roviaro G. New trends in the surgical treatment of outlet obstruction: clinical and functional results of two novel transanal stapled techniques from a randomised controlled trial. Int J Colorectal Dis. 2004 Jul;19(4):359-69. doi: 10.1007/s00384-003-0572-2. Epub 2004 Mar 13.
Results Reference
background
PubMed Identifier
15349740
Citation
Pescatori M, Dodi G, Salafia C, Zbar AP. Rectovaginal fistula after double-stapled transanal rectotomy (STARR) for obstructed defaecation. Int J Colorectal Dis. 2005 Jan;20(1):83-5. doi: 10.1007/s00384-004-0658-5. Epub 2004 Sep 2. No abstract available.
Results Reference
background
PubMed Identifier
15741014
Citation
Grassi R, Romano S, Micera O, Fioroni C, Boller B. Radiographic findings of post-operative double stapled trans anal rectal resection (STARR) in patient with obstructed defecation syndrome (ODS). Eur J Radiol. 2005 Mar;53(3):410-6. doi: 10.1016/j.ejrad.2004.12.012.
Results Reference
background
PubMed Identifier
16035252
Citation
Mongardini M, Custureri F, Schillaci F, Cola A, Maturo A, Fanello G, Corelli S, Pappalardo G. [Prevention of post-operative pain and haemorrhage in PPH (Procedure for Prolapse and Hemorrhoids) and STARR (Stapled Trans-Anal Rectal Resection). Preliminary results in 261 cases]. G Chir. 2005 Apr;26(4):157-61. Italian.
Results Reference
background
PubMed Identifier
15991070
Citation
Binda GA, Pescatori M, Romano G. The dark side of double-stapled transanal rectal resection. Dis Colon Rectum. 2005 Sep;48(9):1830-1; author reply 1831-2. doi: 10.1007/s10350-005-0103-z. No abstract available.
Results Reference
background
PubMed Identifier
15962257
Citation
Jayne DG, Finan PJ. Stapled transanal rectal resection for obstructed defaecation and evidence-based practice. Br J Surg. 2005 Jul;92(7):793-4. doi: 10.1002/bjs.5092. No abstract available.
Results Reference
background
PubMed Identifier
2232900
Citation
Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov;65(11):1456-79. doi: 10.1016/s0025-6196(12)62169-7.
Results Reference
background

Learn more about this trial

Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)

We'll reach out to this number within 24 hrs